Feinstein Institutes for Medical Research

Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize

Retrieved on: 
Thursday, November 2, 2023
Science, Health, Neurology, Research, Sequence, Feinstein Institutes for Medical Research, Inflammation, Karolinska Institute, Doctor of Philosophy, Rheumatoid arthritis, Biomedical sciences, Shock, Immunity, Neuroscience, Boston University, Neurosurgery, Death, Rockefeller University, Medical research, Hope, Nobel Committee, Vagus nerve stimulation, Reflex, Cytokine, Boston College, Royal Academies for Science and the Arts of Belgium, Northwell Health, Medicine, Credit, UNESCO Science Prize, Patient, Vagus nerve, Septic shock, Human, University Medical Center, BS, Laboratory, Travel, Olivia Wigzell, Chemistry, Survival, Education, Royal Academy of Arts, Water, Multimedia, Dana, Engineering, Rockefeller, Student, Dana Foundation, Sepsis, Inflammatory bowel disease, Nursing, Pharmaceutical industry, Medical device, MD

The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.

Key Points: 
  • The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
  • Dr. Tracey will travel to Stockholm, Sweden, to receive the prize, which includes $100,000, and deliver a lecture on December 1.
  • View the full release here: https://www.businesswire.com/news/home/20231102553265/en/
    Dr. Kevin J. Tracey has been named awardee of the 2023 Hans Wigzell Research Foundation's Science Prize.
  • “The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases,” said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Dr. Kevin J. Tracey receives Hans Wigzell Research Foundation's Science Prize amounting to USD 100.000

Retrieved on: 
Thursday, November 2, 2023
Medical research, Feinstein Institutes for Medical Research, Vagus nerve stimulation, Inflammation, Doctor of Philosophy, Rheumatoid arthritis, Research, Northwell Health, Neuroscience, Value Partners (asset management), USD, Patient, Inflammatory bowel disease, Pharmaceutical industry, MD

STOCKHOLM, Nov. 2, 2023 /PRNewswire/ -- The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research.

Key Points: 
  • STOCKHOLM, Nov. 2, 2023 /PRNewswire/ -- The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research.
  • Dr. Tracey receives the prize of USD 100.000 for his contributions to the fields of neuroscience and neuroimmunology and his pioneering discoveries in vagus nerve stimulation, the inflammatory reflex and bioelectronic medicine.
  • Dr. Tracey's discovery of the body's "inflammatory reflex" – a neural circuit regulating inflammatory responses, is on of his most important achievements.
  • "The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases," said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Feinstein Institutes Awarded $6.1M to Fund Bipolar Disorder Patient and Research Hub

Retrieved on: 
Thursday, October 19, 2023
Mental Health, Health, Biometrics, Clinical Trials, Research, Science, Biotechnology, Knowledge, Patient, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Medical research, Feinstein, Feinstein Institutes for Medical Research, Transcranial magnetic stimulation, Johns Hopkins University, Zucker Hillside Hospital, Hofstra University, Psychiatry, Bipolar disorder, Multimedia, Donald, Clinical trial, Schizophrenia, Institutional review board, Behavioural sciences, Credit, University, Magnetic resonance imaging, University of California, Los Angeles, BD2, University of Michigan, Hospital, BSN, Mayo Clinic, Pharmaceutical industry, MD, Brigham, Wellcome

Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.

Key Points: 
  • Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.
  • Through a national research grant and innovative networking system aimed to connect patients to care, it might become easier for people with bipolar disorder to find new treatments and clinical trials.
  • (Credit: Feinstein Institutes)
    Researchers at The Feinstein Institutes for Medical Research received a $6.1 million grant from Breakthrough Discoveries for Thriving with Bipolar Disorders Foundation (BD2) to serve as a hub of six other sites across the country.
  • “Although bipolar disorder impacts millions of Americans every year, it is under-researched,” said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.

Vagus nerve stimulation reduces inflammation in children with Inflammatory Bowel Disease, Feinstein Institutes study finds

Retrieved on: 
Wednesday, October 18, 2023
Research, Managed Care, General Health, Consumer, Medical Devices, Children, Science, Biotechnology, Neurology, Practice Management, Other Science, Health, Abdominal pain, Child, MRI, Medical research, Feinstein, Inflammation, Feinstein Institutes for Medical Research, Cohen, FC, Vagus nerve, Weatherall Institute of Molecular Medicine, Heart rate, Diarrhea, Human, Medicine, Prevalence, Vagus nerve stimulation, Incontinence, Diabetes, Rheumatoid arthritis, MBA, Electricity, TENS, Bleeding, GE Research, Ulcerative colitis, Multimedia, Northwell Health, Disease, Clinical trial, Nature Communications, Pulmonary hypertension, Neuroscience, Ear, Arthritis, IBD, Sickle Cell Anemia, a Molecular Disease, Credit, Molecular medicine, Brain, Cancer, Patient, Liver disease, Biomedical engineering, Bangladesh Technical Education Board, MS, Central nervous system, Lupus, Medical imaging, Pharmaceutical industry, Management, Gastroenterology, MD

View the full release here: https://www.businesswire.com/news/home/20231018401966/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231018401966/en/
    The Feinstein Institutes for Medical Research’s Dr. Benjamin Sahn led the vagus nerve stimulation clinical trial.
  • Inflammation and the inflammatory reflex – the neuronal signaling between the brain and body – is an important immune response.
  • Previous research and functional MRI studies have mapped stimulation of the auricular branch of the vagus nerve to activate the same brain regions as implanted devices, confirming this nerve as a suitable non-invasive target to administer vagus nerve stimulation.
  • Also, Feinstein Institutes researchers, in collaboration with GE Research, published research that harnessed ultrasound technology to reduce inflammation in the body non-invasively.

Pathway to Cures Announces Venture Investment in Five Liters

Retrieved on: 
Monday, October 16, 2023
Research, General Health, Pharmaceutical, Philanthropy, Fund Raising, Foundation, Clinical Trials, Science, Biotechnology, Other Philanthropy, Other Science, Health, VNS, MBA, Doctor of Philosophy, Litre, Indian Council of Medical Research, Bleeding, Anemia, Sickle cell disease, MD, Northwell Health, Injury, Von Willebrand disease, VWD, Electricity, Vagus nerve stimulation, Medical research, Desmopressin, Feinstein Institutes for Medical Research, Coagulopathy, Haemophilia, Scientific Advisory Group, Tan, Hemostasis, Nature Communications, Cyclic permutation, Blood, Vagus nerve, Patient, Pharmaceutical industry, Medical device, The New York Times, Cure, Pathway

Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders.

Key Points: 
  • Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders.
  • Pathway to Cures, an affiliate of the National Bleeding Disorders Foundation, is a venture philanthropy fund focused on early-stage companies developing cures, therapies, or enabling technologies in support of the inheritable blood and bleeding disorders community.
  • This significant milestone is made possible through Five Liters' collaboration with Northwell Health’s Feinstein Institutes for Medical Research in New York.
  • Dr. Recht is Chief Medical and Scientific Officer at both Pathway to Cures and the National Bleeding Disorders Foundation (NBDF) and chairs the Pathway to Cures Scientific Advisory Group.

Feinstein Institutes secures $4M from NIH to study Black maternal health interventions

Retrieved on: 
Thursday, October 5, 2023
Research, Nursing, Women, Baby, Maternity, Managed Care, Health, Consumer, General Health, Science, Diagnosis, Woman, Incidence, Feinstein Institutes for Medical Research, Multimedia, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Disease, Doctor of Philosophy, Mother, Credit, Death, National Institute of Nursing Research, Bleeding, Pre-eclampsia, Organization, Northwell Health, Risk, Social support, MPH, Mortality, Maternal health, SMM, NINR, Feinstein, Comparison, Medical research, Black, Bangladesh Technical Education Board, Nursing Research, Birth control, MD

Researchers at The Feinstein Institutes for Medical Research at Northwell Health were awarded $4 million from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, to study effective maternal health interventions.

Key Points: 
  • Researchers at The Feinstein Institutes for Medical Research at Northwell Health were awarded $4 million from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, to study effective maternal health interventions.
  • View the full release here: https://www.businesswire.com/news/home/20231005320763/en/
    Feinstein Institutes’ Dr. Stephanie L. Fitzpatrick is co-principal investigator on the new research to study maternal health outcomes interventions.
  • Explore the role of physical activity from study enrollment to 1-year postpartum and subsequent association with maternal health outcomes.
  • In 2022, the health system formed its Center for Maternal Health , led by Dawnette Lewis, MD, MPH .

Feinstein Institutes Study Warns of Looming Nationwide Shortage of General Internal Medicine Doctors

Retrieved on: 
Thursday, September 21, 2023
General Health, Hospitals, Health, Science, Research, Workforce, Male, GIM, Hospital medicine, Internal medicine, Feinstein Institutes for Medical Research, Ageing, IM, Multimedia, Medicine, Northwell Health, American College of Physicians, Interface (computing), JAMA Internal Medicine, Student, HM, Patient, Workload, Paper, California Community College Athletic Association, American College, MPH, Credit, Medical research, Dentistry, Nursing, Management, Physician, MD

A new study published in JAMA Internal Medicine from researchers at the Feinstein Institutes for Medical Research suggests that half as many resident doctors are electing general internal medicine careers compared to 10 years ago.

Key Points: 
  • A new study published in JAMA Internal Medicine from researchers at the Feinstein Institutes for Medical Research suggests that half as many resident doctors are electing general internal medicine careers compared to 10 years ago.
  • View the full release here: https://www.businesswire.com/news/home/20230921122380/en/
    Dr. Lauren Block and her team’s new study shows the decline of residents interested in internal medicine.
  • (Credit: Feinstein Institutes)
    The American Association of Medical Colleges projects a shortage of up to 48,000 primary care physicians over the next decade.
  • Block and her team’s research reveals that significantly fewer doctors are choosing general internal medicine as a career choice,” said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.

Leaders to Examine Health Care’s Technological Tipping Point: Northwell Health Hosts Sixth Annual Constellation Forum in NYC

Retrieved on: 
Wednesday, September 20, 2023
FDA, Technology, Pharmaceutical, General Health, Philanthropy, Medical Devices, Artificial Intelligence, Clinical Trials, Foundation, Science, Biotechnology, Software, Other Philanthropy, Health, Research, Constellation, New Frontier, Francis Crick Institute, Human, Big data, Clinton Foundation, Culture, HPE, Health care, Clinical trial, Feinstein Institutes for Medical Research, Cancer, Head, Microsoft, Medicine, Multimedia, Supercomputer, Northwell Health, Doctor of Philosophy, Ethics, MD, Patient, Tetraplegia, Frederick National Laboratory for Cancer Research, Conference on Semantics in Healthcare and Life Sciences, Artificial intelligence, AI, System, MPH, Credit, Medical research, Salesforce, Forum, Catalysis, Pfizer, European High-Performance Computing Joint Undertaking, Medical device, Management

Health care is approaching a scientific and technological tipping point, poised to cross into an age of artificial intelligence (AI) and supercomputing.

Key Points: 
  • Health care is approaching a scientific and technological tipping point, poised to cross into an age of artificial intelligence (AI) and supercomputing.
  • To explore how science, technology, culture and society are converging in medicine, Northwell Health , New York State's largest health system, will host its annual Constellation Forum .
  • View the full release here: https://www.businesswire.com/news/home/20230920880571/en/
    Michael Dowling, president and CEO of Northwell Health will host the sixth annual Constellation Forum.
  • (Credit: Northwell Health)
    Now in its sixth year, the virtual and in-person event will convene on October 5 in New York City starting at 9 a.m.

Feinstein Institutes AI researchers receive $3.1M NIH grant to develop hospital risk and prevention tools

Retrieved on: 
Monday, September 18, 2023
Research, Hospitals, Philanthropy, Fund Raising, General Health, Health, Foundation, Other Philanthropy, Science, Other Science, Medicine, Feinstein Institutes for Medical Research, Respiratory rate, COVID-19, Sleep, Health information management, Nature Communications, NIH, Intelligence, Multimedia, Electronic health record, Scott, Doctor of Philosophy, Bangladesh Technical Education Board, Thermoregulation, CM, Patient, Machine learning, Nursing, Risk, Algorithm, Artificial intelligence, ICU, AI, Heart rate, Credit, Northwell Health, Medical research, Medical device, MD

View the full release here: https://www.businesswire.com/news/home/20230918855998/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230918855998/en/
    Dr. Theodoros Zanos will lead the study team that received the $3.1M NIH grant to develop new AI-powered clinical support tools.
  • The clinical support tools will help clinicians and nurses identify in advance patients at risk of deterioration and clinical reasons to enable timely interventions.
  • “Merging data and technology, researchers and clinicians can work together to develop new tools to improve patient outcomes,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.
  • The Feinstein Institutes continues to invest in the use of technology and artificial intelligence to help improve patient outcomes and bridge health disparities.

Firearms deaths among U.S. children continue to spike, Northwell Health study shows over 40 percent increase

Retrieved on: 
Monday, August 21, 2023
Other Health, Research, Men, General Health, Consumer, Hospitals, Parenting, Children, Science, Women, Other Science, Health, Elmezzi Graduate School of Molecular Medicine, Poverty, Male, Gun violence in the United States, Pediatrics, Violence, Accident, Feinstein Institutes for Medical Research, Hospital, Gun violence, Homicide, Multimedia, Northwell Health, Black, Firearm death rates in the United States by state, Person, Firearm, CDC, Death, WONDER, MD, Patient, Risk, Child, Korea Disease Control and Prevention Agency, Cohen, General surgery, Ageing, Geography, Trauma, Credit, Medical research, Injury, Birth control, Nursing, Drug

New research, led by Northwell Health and the Feinstein Institutes for Medical Research , found a 41.6 percent increase in the firearm death rate among children and adolescents between 2018-2021.

Key Points: 
  • New research, led by Northwell Health and the Feinstein Institutes for Medical Research , found a 41.6 percent increase in the firearm death rate among children and adolescents between 2018-2021.
  • View the full release here: https://www.businesswire.com/news/home/20230821043754/en/
    Dr. Chethan Sathya is the director of Northwell Health’s Center for Gun Violence Prevention.
  • The paper, titled “Trends and Disparities in Firearm Deaths among Children,” showed: From 2018-2021, there was a 41.6 percent increase in the firearm death rate.
  • The time to act is long overdue.”
    Since 2019, Northwell Health has been leading the charge to address gun violence as a public health crisis.